TABLE 4.

Oral and selected topical azole antifungal agents for superficial mycoses

Clinical use	Orala		Oral/topicala	Topical onlya
	ITRA	FLUC	KETO	CLOT	ECON	MICO	OXIC	TERCb	TIOCb
Mucocutaneous candidiasis
Oropharyngeal	√c	√	√d	√e
Esophageal	√c	√	√d
Vaginal/genital	√	√g	√d	√g	√	√g		√h	√h
Cutaneous	√f	√	√	√	√	√	√
Chronic	√f	√	√
Onychomycosis
Candida	√	√	√ (T)a	√	√
Dermatophytes	√	√	√	√	√	√	√		√fh
Dermatophytoses
Tinea corporis/cruris	√	√	√	√	√	√	√
Tinea pedis	√f	√f	√	√	√	√	√
Tinea capitis/barbae	√f	√f	√	√	√	√	√
Pityriasis (tinea) versicolor	√f	√f	√	√	√	√	√

^aITRA, itraconazole; FLUC, fluconazole; KETO, ketoconazole; CLOT, clotrimazole; ECON, econazole; MICO, miconazole; OXIC, oxiconazole; TERC, terconazole; TIOC, tioconazole; (T), topical only. 

^bFor vaginal use only. 

^cOral solution. 

^dSecond-line azole. 

^eTroches. 

^fPromising. 

^gCDC-recommended regimen. 

^hNail lacquer.